Clinical Trials Logo

Clinical Trial Summary

This is a proof-of-principle research study designed to determine whether fecal microbiota transplantation (FMT) can eliminate highly drug-resistant bacteria from the intestinal tract of renal transplant patients. The primary goal of this study is to test whether oral gut decontamination followed by FMT by enema delivery will result in decolonization of the intestinal tract of renal transplant patients shortly after solid organ transplantation, thereby preventing difficult to treat post-transplant infections.


Clinical Trial Description

Contact the study principal investigator for the study protocol. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02906774
Study type Observational
Source University of British Columbia
Contact
Status Terminated
Phase
Start date April 2016
Completion date November 2019

See also
  Status Clinical Trial Phase
Terminated NCT03309358 - A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis Phase 1
Completed NCT02909946 - Pathway From Functional Disability to Antimicrobial Resistance in Nursing Home Residents N/A
Recruiting NCT04335383 - Isolation of Human Recombinant Therapeutic Monoclonal Anti-Pseudomonas Antibodies
Recruiting NCT04181112 - Fecal Transplant for MDRO Decolonization N/A
Completed NCT05048693 - Use of New Antibiotics in Sweden
Completed NCT05897801 - Distinguishing Bacterial and Viral Infections by MeMed BV® Test to Limit Gut Colonization by MDRO
Completed NCT04212130 - Can Environmental Cleanliness be Assessed by BCA (Bicinchoninic Acid) Method N/A
Completed NCT05100407 - Factors Impacting the Prevalence of MDR Bacteria
Completed NCT05549427 - Ventilator Associated Pneumonia by Multi-Drug Resistant Organism
Not yet recruiting NCT06370299 - Screening of Multidrug Resistant Bacteria, and the Clinical Implication for the Patient
Recruiting NCT06148480 - Perinatal Transmission of MDR Bacteria
Recruiting NCT04995133 - Colistin Intravenous Administration in Critically Ill Patients Suffering From Hospital Infections Caused by Multi-antibiotic-resistant Germs. Phase 4
Recruiting NCT03921645 - Use of Aaerosol Combined With Intravenous Antibiotics for the Treatment of Multidrug Resistant GNB Pneumonia N/A
Completed NCT06199141 - Multi-drug Resistant Gram-negative Bacteria and Veno-venous Extracorporeal Membrane Oxygenation (ECMO)
Recruiting NCT04759001 - FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae Phase 1/Phase 2
Not yet recruiting NCT05791396 - FMT to Eradicate Intestinal Colonization by Carbapenem-resistant Enterobacteriaceae Phase 1/Phase 2
Recruiting NCT06036628 - Resistant Bacteria in Children in France